{"id":834666,"date":"2025-04-07T17:09:58","date_gmt":"2025-04-07T21:09:58","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/pliant-therapeutics-announces-upcoming-presentations-at-the-2025-american-thoracic-society-international-conference\/"},"modified":"2025-04-07T17:09:58","modified_gmt":"2025-04-07T21:09:58","slug":"pliant-therapeutics-announces-upcoming-presentations-at-the-2025-american-thoracic-society-international-conference","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/pliant-therapeutics-announces-upcoming-presentations-at-the-2025-american-thoracic-society-international-conference\/","title":{"rendered":"Pliant Therapeutics Announces Upcoming Presentations at the 2025 American Thoracic Society International Conference"},"content":{"rendered":"<div class=\"mw_release\">\n<p align=\"left\">SOUTH SAN FRANCISCO, Calif., April  07, 2025  (GLOBE NEWSWIRE) &#8212; Pliant Therapeutics, Inc. (Nasdaq: PLRX) today announced that the Company will present three scientific posters at the upcoming 2025 American Thoracic Society (ATS) International Conference, taking place in San Francisco, California from May 16-21, 2025.<\/p>\n<p>The following abstracts are posted on ATS 2025\u2019s online itinerary planner for registered users.<\/p>\n<p>Pliant was selected for a featured oral presentation as part of the ATS 2025 Mini Symposiums program.<\/p>\n<p>\n        <strong>Title:<\/strong>\u00a0Characterizing the Antifibrotic Activity of Bexotegrast on Distinct Fibroblast Populations in PCLS From Multiple ILD Subtypes<br \/><strong>Presenter:\u00a0<\/strong>Johanna Schaub, Ph.D., Director of Translational Sciences at Pliant Therapeutics <br \/><strong>Oral Presentation: <\/strong>9696 <br \/><strong>Session B98:<\/strong>\u00a0Cellular interactions and signaling networks in pulmonary fibrosis (mini symposium)<br \/><strong>Date:<\/strong>\u00a0Monday, May 19, 2025<br \/><strong>Presentation Time:<\/strong>\u00a02:15 p.m. \u2013 4:15 p.m. Pacific Time<\/p>\n<p>\n        <strong>Title:<\/strong>\u00a0Plasma Proteome Analysis Reveals Shared and Unique Biomarkers of ILD Subtypes<br \/><strong>Presenter:<\/strong>\u00a0Richard Ahn, Ph.D., Senior Scientist II at Pliant Therapeutics <br \/><strong>Poster:\u00a0<\/strong>12006<br \/><strong>Session D29:<\/strong>\u00a0From bench to bedside: unraveling pulmonary fibrosis through cellular communication and molecular pathways<br \/><strong>Date:<\/strong>\u00a0Wednesday, May 21, 2025<br \/><strong>Presentation Time:<\/strong>\u00a08:15 a.m. \u2013 10:15 a.m. Pacific Time<\/p>\n<p>\n        <strong>Title:<\/strong>\u00a0Single-Cell Profiling Demonstrates the Antifibrotic Effects of Bexotegrast on Pathologic Lung Cell Populations in the Presence and Absence of Background Therapy<br \/><strong>Presenter:<\/strong>\u00a0Mahru An, Ph.D., Principal Scientist at Pliant Therapeutics<br \/><strong>Poster:\u00a0<\/strong>12106<br \/><strong>Session D29:<\/strong>\u00a0From bench to bedside: unraveling pulmonary fibrosis through cellular communication and molecular pathways<br \/><strong>Date:<\/strong>\u00a0Wednesday, May 21, 2025<br \/><strong>Presentation Time:<\/strong>\u00a08:15 a.m. \u2013 10:15 a.m. Pacific Time<\/p>\n<p>Posters will be available to view during the ATS Conference, Sunday, May 18 &#8211; Wednesday, May 21 during the above times for registered users and on the Presentations page of the company website at <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=wdvMiPN5a6fS7vEqKGMn98xblxDrA5v6p0zu8vDdxcheMy7yIHYy-q4xzoREfFrdI6N9cJMgRygqFx7HJduXap5ayyzyoXXewrGqB74zrgQ=\" rel=\"nofollow\" target=\"_blank\">www.PliantRx.com<\/a>.<\/p>\n<p>\n        <strong>About Pliant Therapeutics, Inc.<\/strong>\n      <\/p>\n<p>Pliant Therapeutics is a late-stage biopharmaceutical company and leader in the discovery and development of novel therapeutics for the treatment of fibrotic diseases. Pliant&#8217;s lead product candidate, bexotegrast (PLN-74809), is an oral, small molecule, dual selective inhibitor of \u03b1<sub>v<\/sub>\u00df<sub>6<\/sub> and \u03b1<sub>v<\/sub>\u00df<sub>1<\/sub>\u00a0integrins that is in development in the lead indication for the treatment of idiopathic pulmonary fibrosis, or IPF. Bexotegrast has received Fast Track Designation and Orphan Drug Designation from the U.S. Food and Drug Administration (FDA) and Orphan Drug Designation from the European Medicines Agency in IPF. Pliant is conducting a Phase 1 study for PLN-101095, a small molecule, dual-selective inhibitor of \u03b1<sub>v<\/sub>\u00df<sub>8<\/sub>\u00a0and \u03b1<sub>v<\/sub>\u00df<sub>1<\/sub>\u00a0integrins, that is being developed for the treatment of solid tumors. In addition, Pliant has received regulatory clearance for the conduct of a Phase 1 study of PLN-101325, a monoclonal antibody agonist of integrin \u03b1<sub>7<\/sub>\u03b2<sub>1<\/sub>\u00a0targeting muscular dystrophies.<\/p>\n<p>For additional information, please visit:\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=wdvMiPN5a6fS7vEqKGMn9z9hRSdIJ5RaNRm7qSxGJ4WHWvLJEDUxQNUmckjlJBZto6QNRB3ew9CGHdq2me44-uBy6iRkSY5o7ARJ36LDgA2vycJjGeZip0pfGB4T8wxiihxAqLTVU6C3UmR5pMSHdm7ySRCtLcdO_7U5Aghcd8762JvJ0Kqin8KgRFAG5X7m3ebqSaZn1VRJXmp-m0WxT7Cgr05xP3AysMHx52rNsZI=\" rel=\"nofollow\" target=\"_blank\">www.PliantRx.com<\/a>. Follow us on\u00a0social media\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=6yJ9Oe2e8zKYOcGlukE5f1DWcgCWEvof6EefIIBygtzFV30grYVl09k3c8TcfJ1kVzX5eL1SH65M21lmlKd_zecu8y1Fs4tBq6mabqcZJnEKtrzS1kljv6GXHlCO0v7iyvF7DyE4VXanJsRqm7VEnMg6_ZyfaTCYy6FceP8Riqij3vb01Qk2E6j7DKSlFPFeTnkHE8cxIxtP01f_99iDRQ==\" rel=\"nofollow\" target=\"_blank\">X<\/a>,\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=s1fUSKxtjceZcW9ELaY1KNEVDxr2E-42aUqK4-RMrAvNXHnFxnSkK6sXzHvE6_UL1-m2pEZd5B2Fx1MvcWrJBG37yf_bWOzDezuM3bAxELOxZMCRxLagUfTn2p5HFhxbVonPcFkFvQ7b7t7K-3wEfXPGxi-2cEwH21u4OUmT_ADP-C_fmWmOXB6WiHG3GoWo0rR79ESZm42I1dFxqu-aaC-Ii_PstutXif2ujl2TQTZJbxJ_9g-6shRolMBzuBnD_7aZ0tJZieXJwCByr4n9DQ==\" rel=\"nofollow\" target=\"_blank\">LinkedIn<\/a>, and\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=jf2FUtEy-QghaWmUKbOm9Lg7uAuApdzwpULDcO18WZXxbtgShpe6IGX-hKhFBXzfofU9I7e_oRklvApV8m5hqHIBPWoBGS_EXpM2OWKvYMI15-OvY-m8FtFzdp729EZsmgMDATChk-84wzCKafBS7eD45Cvo9kJUvUaoXGFfRj09xZBq0qHD_amoh5k05iBMIhaoScr6snXzrqGeX02f4de6OOZOXbTMOjZBEcXzfARnpUytgHKSPz0n9tRCcZoU\" rel=\"nofollow\" target=\"_blank\">Facebook<\/a>.<\/p>\n<p>\n        <strong>Investor and Media Contact:<\/strong>\n      <\/p>\n<p>Christopher Keenan<br \/>Vice President, Investor Relations and Corporate Communications<br \/>Pliant Therapeutics, Inc.<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=yXD01i_MSWOD7Bmuw-M5eVlCjIFeKBGUOaaWyqy5aLMzVhKztOLb4DhXqRbMPhk2EPab2gIhHQkkL6o_mPEPcDCX3YLNt3rM9ZUQIm9RkHg-M-HlGrditA3o5lKg4g_Weunc8vfmX_88Z5d7Rgct06oDq6Z4panu98waR8sfxX1W_dqsBhbyIZLfRaHK37CZ8a5--ZbDxAo5LBHEqYLBgQCIyixrI-ahCy_09mFNRwc=\" rel=\"nofollow\" target=\"_blank\">ir@pliantrx.com<\/a><\/p>\n<p>      <img decoding=\"async\" alt=\"\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTQxODA0NiM2ODMwMDU4IzIxODU0NzY=\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" alt=\"\" src=\"https:\/\/ml.globenewswire.com\/media\/ZjE0ZWM0YTYtNzZiOS00YWRjLWEyYjMtNWY0MjgwZTY3NjExLTExOTcwMzAtMjAyNS0wNC0wNy1lbg==\/tiny\/Pliant-Therapeutics-Inc-.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>SOUTH SAN FRANCISCO, Calif., April 07, 2025 (GLOBE NEWSWIRE) &#8212; Pliant Therapeutics, Inc. (Nasdaq: PLRX) today announced that the Company will present three scientific posters at the upcoming 2025 American Thoracic Society (ATS) International Conference, taking place in San Francisco, California from May 16-21, 2025. The following abstracts are posted on ATS 2025\u2019s online itinerary planner for registered users. Pliant was selected for a featured oral presentation as part of the ATS 2025 Mini Symposiums program. Title:\u00a0Characterizing the Antifibrotic Activity of Bexotegrast on Distinct Fibroblast Populations in PCLS From Multiple ILD SubtypesPresenter:\u00a0Johanna Schaub, Ph.D., Director of Translational Sciences at Pliant Therapeutics Oral Presentation: 9696 Session B98:\u00a0Cellular interactions and signaling networks in pulmonary fibrosis (mini symposium)Date:\u00a0Monday, May 19, 2025Presentation Time:\u00a02:15 p.m. &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/pliant-therapeutics-announces-upcoming-presentations-at-the-2025-american-thoracic-society-international-conference\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Pliant Therapeutics Announces Upcoming Presentations at the 2025 American Thoracic Society International Conference&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-834666","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Pliant Therapeutics Announces Upcoming Presentations at the 2025 American Thoracic Society International Conference - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/pliant-therapeutics-announces-upcoming-presentations-at-the-2025-american-thoracic-society-international-conference\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Pliant Therapeutics Announces Upcoming Presentations at the 2025 American Thoracic Society International Conference - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"SOUTH SAN FRANCISCO, Calif., April 07, 2025 (GLOBE NEWSWIRE) &#8212; Pliant Therapeutics, Inc. (Nasdaq: PLRX) today announced that the Company will present three scientific posters at the upcoming 2025 American Thoracic Society (ATS) International Conference, taking place in San Francisco, California from May 16-21, 2025. The following abstracts are posted on ATS 2025\u2019s online itinerary planner for registered users. Pliant was selected for a featured oral presentation as part of the ATS 2025 Mini Symposiums program. Title:\u00a0Characterizing the Antifibrotic Activity of Bexotegrast on Distinct Fibroblast Populations in PCLS From Multiple ILD SubtypesPresenter:\u00a0Johanna Schaub, Ph.D., Director of Translational Sciences at Pliant Therapeutics Oral Presentation: 9696 Session B98:\u00a0Cellular interactions and signaling networks in pulmonary fibrosis (mini symposium)Date:\u00a0Monday, May 19, 2025Presentation Time:\u00a02:15 p.m. &hellip; Continue reading &quot;Pliant Therapeutics Announces Upcoming Presentations at the 2025 American Thoracic Society International Conference&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/pliant-therapeutics-announces-upcoming-presentations-at-the-2025-american-thoracic-society-international-conference\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2025-04-07T21:09:58+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTQxODA0NiM2ODMwMDU4IzIxODU0NzY=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/pliant-therapeutics-announces-upcoming-presentations-at-the-2025-american-thoracic-society-international-conference\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/pliant-therapeutics-announces-upcoming-presentations-at-the-2025-american-thoracic-society-international-conference\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Pliant Therapeutics Announces Upcoming Presentations at the 2025 American Thoracic Society International Conference\",\"datePublished\":\"2025-04-07T21:09:58+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/pliant-therapeutics-announces-upcoming-presentations-at-the-2025-american-thoracic-society-international-conference\\\/\"},\"wordCount\":461,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/pliant-therapeutics-announces-upcoming-presentations-at-the-2025-american-thoracic-society-international-conference\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTQxODA0NiM2ODMwMDU4IzIxODU0NzY=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/pliant-therapeutics-announces-upcoming-presentations-at-the-2025-american-thoracic-society-international-conference\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/pliant-therapeutics-announces-upcoming-presentations-at-the-2025-american-thoracic-society-international-conference\\\/\",\"name\":\"Pliant Therapeutics Announces Upcoming Presentations at the 2025 American Thoracic Society International Conference - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/pliant-therapeutics-announces-upcoming-presentations-at-the-2025-american-thoracic-society-international-conference\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/pliant-therapeutics-announces-upcoming-presentations-at-the-2025-american-thoracic-society-international-conference\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTQxODA0NiM2ODMwMDU4IzIxODU0NzY=\",\"datePublished\":\"2025-04-07T21:09:58+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/pliant-therapeutics-announces-upcoming-presentations-at-the-2025-american-thoracic-society-international-conference\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/pliant-therapeutics-announces-upcoming-presentations-at-the-2025-american-thoracic-society-international-conference\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/pliant-therapeutics-announces-upcoming-presentations-at-the-2025-american-thoracic-society-international-conference\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTQxODA0NiM2ODMwMDU4IzIxODU0NzY=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTQxODA0NiM2ODMwMDU4IzIxODU0NzY=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/pliant-therapeutics-announces-upcoming-presentations-at-the-2025-american-thoracic-society-international-conference\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Pliant Therapeutics Announces Upcoming Presentations at the 2025 American Thoracic Society International Conference\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Pliant Therapeutics Announces Upcoming Presentations at the 2025 American Thoracic Society International Conference - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/pliant-therapeutics-announces-upcoming-presentations-at-the-2025-american-thoracic-society-international-conference\/","og_locale":"en_US","og_type":"article","og_title":"Pliant Therapeutics Announces Upcoming Presentations at the 2025 American Thoracic Society International Conference - Market Newsdesk","og_description":"SOUTH SAN FRANCISCO, Calif., April 07, 2025 (GLOBE NEWSWIRE) &#8212; Pliant Therapeutics, Inc. (Nasdaq: PLRX) today announced that the Company will present three scientific posters at the upcoming 2025 American Thoracic Society (ATS) International Conference, taking place in San Francisco, California from May 16-21, 2025. The following abstracts are posted on ATS 2025\u2019s online itinerary planner for registered users. Pliant was selected for a featured oral presentation as part of the ATS 2025 Mini Symposiums program. Title:\u00a0Characterizing the Antifibrotic Activity of Bexotegrast on Distinct Fibroblast Populations in PCLS From Multiple ILD SubtypesPresenter:\u00a0Johanna Schaub, Ph.D., Director of Translational Sciences at Pliant Therapeutics Oral Presentation: 9696 Session B98:\u00a0Cellular interactions and signaling networks in pulmonary fibrosis (mini symposium)Date:\u00a0Monday, May 19, 2025Presentation Time:\u00a02:15 p.m. &hellip; Continue reading \"Pliant Therapeutics Announces Upcoming Presentations at the 2025 American Thoracic Society International Conference\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/pliant-therapeutics-announces-upcoming-presentations-at-the-2025-american-thoracic-society-international-conference\/","og_site_name":"Market Newsdesk","article_published_time":"2025-04-07T21:09:58+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTQxODA0NiM2ODMwMDU4IzIxODU0NzY=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/pliant-therapeutics-announces-upcoming-presentations-at-the-2025-american-thoracic-society-international-conference\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/pliant-therapeutics-announces-upcoming-presentations-at-the-2025-american-thoracic-society-international-conference\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Pliant Therapeutics Announces Upcoming Presentations at the 2025 American Thoracic Society International Conference","datePublished":"2025-04-07T21:09:58+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/pliant-therapeutics-announces-upcoming-presentations-at-the-2025-american-thoracic-society-international-conference\/"},"wordCount":461,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/pliant-therapeutics-announces-upcoming-presentations-at-the-2025-american-thoracic-society-international-conference\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTQxODA0NiM2ODMwMDU4IzIxODU0NzY=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/pliant-therapeutics-announces-upcoming-presentations-at-the-2025-american-thoracic-society-international-conference\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/pliant-therapeutics-announces-upcoming-presentations-at-the-2025-american-thoracic-society-international-conference\/","name":"Pliant Therapeutics Announces Upcoming Presentations at the 2025 American Thoracic Society International Conference - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/pliant-therapeutics-announces-upcoming-presentations-at-the-2025-american-thoracic-society-international-conference\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/pliant-therapeutics-announces-upcoming-presentations-at-the-2025-american-thoracic-society-international-conference\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTQxODA0NiM2ODMwMDU4IzIxODU0NzY=","datePublished":"2025-04-07T21:09:58+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/pliant-therapeutics-announces-upcoming-presentations-at-the-2025-american-thoracic-society-international-conference\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/pliant-therapeutics-announces-upcoming-presentations-at-the-2025-american-thoracic-society-international-conference\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/pliant-therapeutics-announces-upcoming-presentations-at-the-2025-american-thoracic-society-international-conference\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTQxODA0NiM2ODMwMDU4IzIxODU0NzY=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTQxODA0NiM2ODMwMDU4IzIxODU0NzY="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/pliant-therapeutics-announces-upcoming-presentations-at-the-2025-american-thoracic-society-international-conference\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Pliant Therapeutics Announces Upcoming Presentations at the 2025 American Thoracic Society International Conference"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/834666","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=834666"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/834666\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=834666"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=834666"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=834666"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}